Up-regulation of chemokine C-C ligand 2 (CCL2) and C-X-C chemokine 8 (CXCL8) expression by monocytes in chronic idiopathic urticaria

Imagem de Miniatura
Arquivos
art_SANTOS_Up_regulation_of_chemokine_C_C_ligand_2_2012.PDF (503.63 KB)
Citações na Scopus
27
Tipo de produção
article
Data de publicação
2012
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY-BLACKWELL
Autores
Citação
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, v.167, n.1, p.129-136, 2012
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The disturbed cytokinechemokine network could play an important role in the onset of diseases with inflammatory processes such as chronic idiopathic urticaria (CIU). Our main objectives were to evaluate the relation between proinflammatory chemokine serum levels from CIU patients and their response to autologous skin test (ASST) and basophil histamine release (BHR). We also aimed to assess the chemokine secretion by peripheral blood mononuclear cells (PBMC) upon polyclonal stimulus and to evaluate chemokine CC ligand 2/C-X-C chemokine 8 (CCL2/CXCL8) and Toll-like receptor-4 (TLR-4) expression in monocytes. We observed significantly higher serum levels of the CXCL8, CXCL9, CXCL10 and CCL2 in CIU patients compared to the healthy group, regardless of the BHR or ASST response. The basal secretion of CCL2 by PBMC or induced by Staphylococcus aureus enterotoxin A (SEA) was higher in CIU patients than in the control group, as well as for CXCL8 and CCL5 secretions upon phytohaemagglutinin stimulation. Also, up-regulation of CCL2 and CXCL8 mRNA expression was found in monocytes of patients upon SEA stimulation. The findings showed a high responsiveness of monocytes through CCL2/CXCL8 expression, contributing to the creation of a proinflammatory environment in CIU.
Palavras-chave
chemokines, chronic idiopathic urticaria, innate immunity, monocytes
URI
https://observatorio.fm.usp.br/handle/OPI/572
Referências
  1. BAGGIOLINI M, 1989, J CLIN INVEST, V84, P1045, DOI 10.1172/JCI114265
  2. Baggiolini M, 1997, ANNU REV IMMUNOL, V15, P675, DOI 10.1146/annurev.immunol.15.1.675
  3. Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129
  4. Caproni M, 2004, J DERMATOL SCI, V36, P57, DOI 10.1016/j.jdermsci.2004.07.006
  5. Castellani ML, 2010, J BIOL REG HOMEOS AG, V24, P1
  6. Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723
  7. CHOI YW, 1990, NATURE, V346, P471, DOI 10.1038/346471a0
  8. Ciprandi G, 2011, CLIN EXP DERMATOL, V36, P85, DOI 10.1111/j.1365-2230.2010.03914.x
  9. dos Santos JC, 2008, INT IMMUNOPHARMACOL, V8, P1433, DOI 10.1016/j.intimp.2008.05.016
  10. Fulkerson PC, 2005, BLOOD, V106, P436, DOI 10.1182/blood-2005-02-0489
  11. Futata E, 2011, BRIT J DERMATOL, V164, P1271, DOI 10.1111/j.1365-2133.2010.10198.x
  12. Gerszten RE, 1999, NATURE, V398, P718
  13. Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261
  14. Greaves M, 2000, J ALLERGY CLIN IMMUN, V105, P664, DOI 10.1067/mai.2000.105706
  15. Gros E, 2009, J ALLERGY CLIN IMMUN, V124, p[753, e1]
  16. Guttman-Yassky E, 2007, J EUR ACAD DERMATOL, V21, P35, DOI 10.1111/j.1468-3083.2006.01852.x
  17. HIDE M, 1993, NEW ENGL J MED, V328, P1599, DOI 10.1056/NEJM199306033282204
  18. Homey B, 2008, CLIN DERMATOL, V26, P539, DOI 10.1016/j.clindermatol.2007.11.003
  19. Kaplan A, 2010, CLIN EXP ALLERGY, V40, P834, DOI 10.1111/j.1365-2222.2010.03489.x
  20. Kaplan AP, 2009, CLIN EXP ALLERGY, V39, P777, DOI 10.1111/j.1365-2222.2009.03256.x
  21. Karpus WJ, 1997, J IMMUNOL, V158, P4129
  22. Lourenco FD, 2008, BRIT J DERMATOL, V158, P979, DOI 10.1111/j.1365-2133.2008.08499.x
  23. Luquin E, 2005, CLIN EXP ALLERGY, V35, P456, DOI 10.1111/j.1365-2222.2005.02212.x
  24. Mackay CR, 2001, NAT IMMUNOL, V2, P95, DOI 10.1038/84298
  25. Meller S, 2009, J INVEST DERMATOL, V129, P315, DOI 10.1038/jid.2008.251
  26. O'Hayre M, 2008, BIOCHEM J, V409, P635, DOI 10.1042/BJ20071493
  27. Puccetti A, 2005, CLIN EXP ALLERGY, V35, P1599, DOI 10.1111/j.1365-2222.2005.02380.x
  28. Rose CE, 2003, MICROCIRCULATION, V10, P273, DOI 10.1038/sj.mn.7800193
  29. Rotondi M, 2004, AM J TRANSPLANT, V4, P1466, DOI 10.1111/j.1600-6143.2004.00525.x
  30. Sabroe RA, 1998, J ALLERGY CLIN IMMUN, V102, P651, DOI 10.1016/S0091-6749(98)70283-0
  31. Sabroe RA, 1999, BRIT J DERMATOL, V140, P446
  32. Takahasi HK, 2003, CLIN IMMUNOL, V108, P274, DOI 10.1016/S1521-6616(03)00140-2
  33. Taub DD, 1996, J IMMUNOL, V156, P2095
  34. Tedeschi A, 2007, CLIN EXP DERMATOL, V32, P568, DOI 10.1111/j.1365-2230.2007.02450.x
  35. Weber C, 2000, J LEUKOCYTE BIOL, V67, P699
  36. Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X

Coleções
Artigos e Materiais de Revistas Científicas - FM/MDT
Artigos e Materiais de Revistas Científicas - FM/MPT
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/03
Artigos e Materiais de Revistas Científicas - LIM/56